NCT05560308 2022-10-03Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI TherapyTianjin Medical University Cancer Institute and HospitalPhase NA Unknown50 enrolled